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Background: Little is known about the characteristics and real world life circumstances of ARDS (acute 
respiratory distress syndrome) patient populations. This knowledge is essential for transferring evidence-
based therapy into routine healthcare. The aim of this study was to report socio-demographic and clinical 
characteristics in an unselected population of ARDS patients and to compare these results to findings from 
other large ARDS cohorts.
Methods: A German based cross-sectional observational study was carried out. A total of 700 ARDS 
patients were recruited in 59 study sites between September 2014 and January 2016. Socio-demographic, 
disease and care related variables were recorded. Additionally, characteristics of other large ARDS cohorts 
identified by a systematic literature search were extracted into evidence tables.
Results: Median age of ARDS patients was 58 years, 69% were male. Sixty percent had no employment, 
predominantly due to retirement. Seventy-one percent lived with a partner. The main cause of ARDS was a 
pulmonary ‘direct’ origin (79%). The distribution of severity was as follows: mild (14%), moderate (48%), 
severe (38%). Overall ICU mortality was calculated to be 34%. The observed prevalence of critical events 
(hypoxemia, hypoglycemia, re-intubation) was 47%. Supportive measures during ICU-treatment were 
applied to 60% of the patients. Other ARDS cohorts revealed a high heterogeneity in reported concomitant 
diseases, but sepsis and pneumonia were most frequently reported. Mean age ranged from 54 to 71 years and 
most patients were male. Other socio-demographic factors have been almost neglected.
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Introduction
The acute respiratory distress syndrome (ARDS) is a 
life-threatening condition characterized by either direct or 
indirect damage to the lung parenchyma causing critical 
hypoxemia and potentially hypercapnia and resulting in 
mechanical ventilation (1). In the year 2011 the Berlin-
Definition revised and modified the American-European 
Consensus (AECC) diagnostic criteria of ARDS and 
acute lung injury (ALI) (2) that had been applied until 
that point. As a consequence the distinction between 
ARDS and ALI was removed and ARDS was classified in 
mild, moderate, and severe stages depending on the ratio 
of partial pressure arterial oxygen PaO2 and fraction of 
inspired oxygen FiO2 (PaO2/FIO2-ratio) (3). Even though a 
broad range of interventions to manage ARDS in intensive 
care was investigated and partly recommended in recent 
years, evidence that all these measures can substantially 
decrease mortality is still limited (4). Most of the evidence 
stems from high quality randomized controlled trials (RCTs) 
that include highly selected populations in strictly defined 
clinical settings. Data from such RCTs are urgently needed, 
but external validity is often limited. Therefore, transferring 
evidence from high quality RCTs into routine healthcare 
is problematic and effects found in RCTs will likely not be 
reproduced. Data collected in everyday life and/or everyday 
routine care are called real world data (RWD) (5) and are 
important to understand the complexities of ARDS outside 
the clinical trials setting. RWD obtained by observational 
study designs allow to investigate exposures, which are 
impossible to manipulate experimentally due to tight 
integration with the studied patients or ethical concerns. In 
this context some lifestyle risk factors such as cigarette smoke 
exposure or alcohol abuse (6), socio-demographic factors 
such as race and gender (7), and clinical comorbidity (8) 
have been investigated in rather small cohorts of ARDS 
patients. Larger cohorts allow to describe the clinical 
epidemiology of ARDS and to analyse associations between 
patient characteristics or care related factors and outcome 
measures. In this context, a closer look reveals a high degree 
of variability between different cohorts/samples. Some 
studies display major differences regarding to incidence and 
mortality (9). One reason for this variability might be that 
most European countries like the United Kingdom (10) 
or Germany (11) show considerable differences in the 
management of ARDS or other critical illnesses due the 
non-central clinical governance of health care provision.
Generally, there is a lack of descriptive socio-demographic 
and health care related data based on large and representative 
ARDS cohorts/samples. Therefore, we used data from the 
first 700 ARDS-patients enrolled in the DACAPO-Cohort 
[DACAPO: Surviving ARDS: The influence of quality of care 
and individual patient characteristics on health related quality 
of life and return to work in survivors of the ARDS] (12) 
for a descriptive analysis of socio-demographic and clinical 
characteristics as well as care-related factors of ARDS 
patients during intensive care unit (ICU) treatment. Our 
second aim was to compare the characteristics of the 
DACAPO cohort with findings of other large, multi-centric 
cohort studies. 
Methods
Design and setting
Data were obtained from a large Germany-wide prospective 
cohort study [DACAPO study (12), ClinicalTrials.gov 
Identifier: NCT02637011]. Briefly, the DACAPO study 
investigates the influence of quality of care and individual 
patient characteristics on health-related quality of life 
(HRQoL) and return to work in survivors of ARDS. The 
data presented in this paper were collected once during 
Conclusions: The proportion of patients suffering of mild ARDS was lower compared to the only study 
identified, which also applied the Berlin definition. The frequency of critical events during ICU treatment 
was high and the implementation of evidence-based therapy (prone positioning, neuro-muscular blockers) 
was limited. More evidence on socio-demographic characteristics and further studies applying the current 
diagnostic criteria are desirable. 
Keywords: Acute respiratory distress syndrome (ARDS); intensive care units (ICUs); lung; rescue measures
Submitted Jun 29, 2016. Accepted for publication Oct 27, 2016.
doi: 10.21037/jtd.2017.03.120
View this article at: http://dx.doi.org/10.21037/jtd.2017.03.120
820 Dodoo-Schittko et al. Characteristics of ARDS patients
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
ICU treatment, the design of the study is thus cross-
sectional. In order to represent the entire spectrum of 
intensive health care service, ICUs with different medical 
specialization were invited all over Germany to participate 
in the DACAPO-study. Finally, 59 ICUs of 415 German 
hospitals with at least one department for intensive care (13) 
contributed eligible patients to the DACAPO cohort. 
Eligibility and identification of cases 
Inclusion criteria for patient enrolment were the presence 
of an ARDS according to the Berlin definition (3) and being 
18 years of age or older. No exclusion criteria were applied. 
ARDS was diagnosed by the medical team of the 
respective study site. In order to minimize sources of 
selection and information bias the responsible physicians 
and study nurses of the participating ICUs underwent a 
training regarding to the diagnostic criteria of ARDS Berlin 
definition, the assessment and the documentation of the 
medical and socio-demographic characteristics of interest. 
Because of the consecutive inclusion of the participating 
ICUs, the period of patient recruitment varied between the 
study sites. Overall, 700 patients were enrolled in 59 study 
sites from September 2014 to January 2016. Data of these 
first 700 patients of the DACAPO-cohort were analysed for 
the purpose of this study. 
Measures and data collection
We present descriptive data on the following variables of 
interest: 
(I) General characteristics of participating study sites 
(e.g., level of care, university hospital) and their 
recruitment activities are reported;
(II) Socio-demographic characteristics of patients include 
sex, age, educational and professional level, current 
employment and living situation. This information 
was provided by patients, patients’ caregivers or legal 
guardians;
Clinical parameters comprise cause and severity of 
ARDS, diagnosis and therapeutic aim at admission as well 
as the presence of selected comorbidities. The Sequential 
Organ Failure Assessment score (SOFA) (14) and the 
Simplified Acute Physiology Score II (SAPS II) (15) were 
used to assess severity of illness at admission. Both scores 
were calculated according to the published algorithms 
(14,15). Additionally, the length of stay at ICU until death 
or discharge, the occurrence of critical events [hypoxemia 
(SpO2 <85% for at least 5 min), hypoglycemia (defined 
as blood glucose measurement <70 mg/dL), accidental 
extubation, re-intubation] was assessed. In the clinical 
intensive care setting, an arterial SpO2 <85%, corresponding 
to a PaO2 ≤50 mmHg with a time span of a few minutes, is 
accepted as a valuable marker for hypoxemia (16,17). The 
advocated measures in these situations are the control of 
artificial airways and ventilator function/modes/settings, 
the suction of endotracheal secretions, the acute use of 
open lung approaches, and/or acute imaging diagnostics 
(Chest X-ray, ultrasound). In addition the use of supportive 
measures [tracheotomy, NO-inhalation, extracorporeal 
membrane oxygenation (ECMO), prone positioning, neuro-
muscular blockers] was recorded. 
All clinical parameters were prospectively assessed and 
entered in electronic case report forms (eCRFs) by trained 
physicians or study personnel at individual study sites. 
Statistics
Total scores were calculated only for patients without 
missing data on the item level. Descriptive statistics were 
calculated. Dichotomous or categorical parameters are 
presented in frequencies and percentages. Median (Md) and 
interquartile range (IQR) were calculated for continuous 
variables. All analyses were computed using IBM SPSS 
Statistics (version 21).
Systematic literature search
Additionally, we performed a systematic electronic search 
for observational studies of ARDS patients. We included 
only multi centre (more than one study site) studies with 
observational study design (cohort, case control, cross-
sectional) and cohorts/samples larger than 200 patients in 
developed countries which were published from 01/01/2000 
to 01/02/2016. To ensure high external validity of the 
reported findings, only cohorts/samples of ARDS patients 
without any exclusion criteria were selected. The retrieval 
of studies was performed in PubMed using the combined 
filter and Medical Subject Headings (MeSH) term: 
((((“Respiratory Distress Syndrome, Adult”[MeSH Major 
Topic] AND (“2000/01/01”[PDAT] : “3000”[PDAT])) 
AND (“english”[Language] OR “german”[Language])) 
NOT animal[Filter]) AND “epidemiologic studies”[MeSH 
Terms]) NOT all child[Filter]. In a first step, the records 
were screened by two pairs of raters on the basis of title 
and abstract independently. Finally, the remaining records 
821Journal of Thoracic Disease, Vol 9, No 3 March 2017
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
were appraised in detail by reading the full-text paper. 
Discrepancies were discussed between raters until consensus 
was achieved. All relevant characteristics of ARDS patients 
and medical care reported in the papers were extracted into 
evidence tables. 
Results
Findings in the DACAPO-cohort
Thirty-eight (64%) of the 59 participating ICUs were 
centres of the German ARDS Network (18) and 30 ICUs of 
university hospitals participated (Table 1). As intended by the 
strategy which was applied to select the participating study 
sites, these comprised ICUs with different specializations 
(e.g., surgery/operative, anesthesia, internal medicine) and 
of various sizes and were heterogeneous regarding level of 
care.
Socio-demographic characteristics are presented in 
Table 2. Two-thirds of the patients were male and median 
age was 58 (IQR =46.0–69.0) years. 16% of patients had a 
high schooling level qualifying for university entrance and 
12% had no professional qualification. About a quarter 
of the sample (27%) were in full-time employment, the 
predominant reason for unemployment was retirement 
(71%). 61 % were married/in a civil partnership and 71% 
lived with a partner. Important medical characteristics at 
ICU admission are displayed in Table 3. SAPS-II- (Md =46; 
IQR =36.0–58.0) and SOFA-scores (Md =9; IQR =7.0–11.0) 
represent a certain cohort of critically ill patients. Especially 
cardiovascular and renal dysfunctions led to elevated SOFA 
item scores. The most frequent comorbidities included 
cancer and alcohol disorder. About one third (29%) of 
patients were obese (body mass index ≥30 kg/m2).
The main cause of ARDS was of pulmonary ‘direct’ 
origin (79 %) (Table 4). The degree of severity of ARDS 
was unequally distributed in our sample, with nearly half 
of the cases classified as moderate, while ‘mild’ ARDS 
was only present in 14% of cases. At the time of diagnosis 
the median oxygenation level (PaO2/FiO2) was 101.5 
(IQR =70.7–160.0). In one-third of patients (33%), ARDS 
had been diagnosed in referring hospital/ICU, before 
transfer to one of the participating ICUs. The percentage 
of ‘severe’ ARDS tended to be higher in the cohort of 
transferred patients (46% vs. 38% in the entire cohort). 
The leading diagnosis at ICU-admission was ‘respiratory 
disease’, while ‘trauma’ (8%), ‘gastrointestinal/abdominal 
disease’ (6%) or ‘post-surgery’ were rarely noted as main 
diagnoses. ICU mortality was 34%.
The occurrence of critical events and use of supportive 
measures are presented in Table 5. At least one critical event 
occurred in nearly half of the patients. Hypoxemic episodes 
were registered in 27% of patients, and 21% developed 
at least one hypoglycemic situation. A re-intubation was 
performed in 17%. The distribution of the use of supportive 
measures was as follows: less than half of ARDS patients 
received prone positioning (45%) and only a minority 
received neuromuscular blockers (11%). Overall, 425 out 
of 700 patients (61%) received at least one evidence-based 
rescue measure.
Findings in other large ARDS-cohorts
A total of 11 studies met the eligibility criteria applied to 
the studies found by the systematic literature search. Data 
extracted from these studies is shown in Table S1.
Not all cohorts/samples were independent. We identified 
an overlap of included patients in at least three studies (19-21).
A Taiwanese registry-based (National Health Insurance 
Research Database) study included more than 40,000 
ARDS patients (22). Overall, the sample sizes of the studies 
detected by literature search ranged from 255 to 40,876. 
Three out of the 11 studies went beyond a national multi 
centre approach and included different international (23,24) 
or European (25) study sites. 
Most of the large published cohorts/samples applied 
AECC diagnostic criteria. Only the most recent study (23) 
used the Berlin definition of ARDS. 
Studies reported almost exclusively disease related 
factors. Socio-demographic and care related variables 
remained largely neglected. Exceptions were age (measures 
of central tendency ranged from 54 to 71 years) and sex 
(surplus of women in only one cohort). Mortality ranged 
Table 1 Characteristics of 59 participating ICUs
Characteristics 59 ICUsa
Center of the German ARDS Network, N (%) 38 (64.4)
ICU’s of University hospitals, N (%) 30 (50.8)
Maximum level of careb, N (%) 35 (59.3)
Duration of recruitment (weeks), Md [IQR] 55 [42–61]
a, with at least one patient included in this paper; b, maximum 
level of care refers to hospitals with highly differentiated 
medical-technical equipment. ICU, intensive care unit; ARDS, 
acute respiratory distress syndrome; Md, median; IQR, 
interquartile range.
822 Dodoo-Schittko et al. Characteristics of ARDS patients
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
Table 2 Socio-demographic characteristics of 700 patients with 
ARDS
Socio-demographic characteristics N n (%) or Md (IQR)
Sex 700
Female 215 (30.7)
Male 485 (69.3)
Age (years) 699 58.0 (46.0–69.0)
Educational level 682
No school leaving certificate 13 (1.9)
Not yet a school leaving certificate 6 (0.9)
Schooling <10 years
Secondary school leaving certificate 256 (37.5)
Schooling =10 years
Intermediate school leaving certificate 202 (29.6)
Schooling >10 years
University entrance level 106 (15.5)
Unknown 99 (14.5)
Professional level 681
Still in professional training 12 (1.8)
No professional qualification 79 (11.6)
Professional qualification 425 (62.4)
University degree 57 (8.4)
Other degree 14 (2.1)
Unknown 94 (13.8)
Current employment 684
Full-time employed 184 (26.9)
Part-time employed 24 (3.5)
Occasionally or unregularly employed 17 (2.5)
Unemployed 407 (59.5)
Unknown 52 (7.6)
 Reason for unemployment 406
Retired 290 (71.4)
Housewife/husband 27 (6.7)
Seeking for employment 34 (8.4)
None of them 51(12.6)
Unknown 4 (1.0)
Table 2 (continued)
Table 2 (continued)
Socio-demographic characteristics N n (%) or Md (IQR)
Nationality 687
German 641 (93.3)
Other 42 (6.1)
Unknown 4 (0.6)
Marital status 686
Married/registered partnership 415 (60.5)
Not married 157 (22.9)
Widowed 44 (6.4)
Divorced/separation of registered 
partnership
50 ( 7.3)
Unknown 20 (2.9)
Living with a partner 687
Yes 487 (70.9)
No 186 (27.1)
Unknown 14 (2.0)
Number of persons in the household 641 2.0 (2.0-3.0)
Residence 688
With permanent residence 678 (98.5)
Homeless 6 (0.9)
Unknown 4 (0.6)
Health insurance 679
Statutory 584 (86.0)
Private 63 (9.3)
Othera 15 (2.2)
Unknown 17 (2.5)
Data was provided by patients’ caregivers/legal guardians. 
Numbers do not add up to N=700 due to missing values. a, 
including non-German health insurances, other compensation, 
no health insurance. ARDS, acute respiratory distress syndrome; 
Md, median; IQR, interquartile range.
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Table 3 General medical characteristics of 700 patients with ARDS
Medical characteristics N n (%) or Md (IQR)
SAPS-IIa score 485 46.0 (36.0–58.0)
SOFA scoreb 390  9 [7–11]
Respiratory 659  3 [3–4]
Coagulation 675 0 (0–2)
Liver 655 0 (0–1)
Cardiovascular 647 3 [3–4]
Central nervous system 459 0 (0–0)
Renal 647 1 (0–2)
Oxygenationb PaO2/FiO2 ratio 657 101.5 (70.7–160.0)
Selected comorbiditiesc (multiple answers) 408
Active cancer therapy  68 (16.7)
Malignancy with distant metastases 24 (5.9)
Hematological malignancy 29 (7.1)
Chronic heart failure (NYHA-IV) 15 (3.7)
AIDS 5 (1.2)
Cirrhosis of the liver 30 (7.3)
Physician diagnosed alcohol disorder  48 (11.8)
None of them  313 (76.7)
BMI 679  26.6 (24.2–31.0)
Obesityd 679  197 (29.0)
ARDS, acute respiratory distress syndrome; Md, median; IQR, interquartile range; SAPS-II score, Simplified Acute Physiology Score II; 
SOFA score, Sequential Organ Failure Assessment; BMI, body mass index; ECMO, extracorporeal membrane oxygenation; NYHA-IV, New 
York Heart Association stage IV; AIDS, acquired immune deficiency syndrome. a, as assessed at admission at the ICU; b, as assessed at 
time of the diagnosis of ARDS; c, according to the SAPS-III score; d, BMI ≥30 kg/m2.
from 33% (26) to 60% (24). SAPS II, APACHE (Acute 
Physiology and Chronic Health Evaluation) II &III and 
SOFA were commonly used measures for general morbidity. 
There was also no clear approach in reporting additional 
diseases. Some of the studies reported comorbidity others 
are limited to causes or risk factors of ARDS. Regardless of 
operationalization, sepsis was the most frequently recorded 
disease, closely followed by pneumonia. 
Discussion
We aimed at providing a comprehensive description of 
700 ARDS patients from the DACAPO cohort baseline, 
in order to add to the body of RWD on ARDS. We found 
that seventy percent of ARDS patients were male and that 
median age was 58 years. The majority of patients lived 
in a 2-person-household with partnership. These socio-
demographic data suggest that the sample is likely reflective 
of the general population of this age in Germany, except for 
sex distribution (13). The latter observation is completely 
in accordance to other cohorts of ARDS patients listed in 
Table S1 and emphasizes the role of male sex as risk factor for 
heart and lung diseases in general and ARDS in particular. 
The finding of a high proportion of elderly patients is highly 
relevant, since old patients surviving a critical illness are at 
high risk for long-term physical and cognitive impairment (27) 
requiring prolonged care of the families and of the medical 
system (28). It must be determined in further health care 
studies, whether elderly patients receive adequate care after 
survival of ARDS. 
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Table 4 Characteristics relating to ARDS and its treatment of 700 patients with ARDS
Disease and treatment related characteristics N n (%) or Md (IQR)
Cause of ARDS 692
Pulmonary 547 (79.0)
Extrapulmonary 127 (18.4)
Not specified 18 (2.6)
Severity of ARDSa 700
Mild 99 (14.1)
Moderate 333 (47.6)
Severe 268 (38.3)
Transferred from other hospital to participating ICU 692
No 461 (66.6) 
Yes 231 (33.4) 
Characteristics of transferred patientsb 231
Sex (female) 82 (35.5)
Age (years) 53.0 (42.0-63.0)
Severe ARDS 121 (45.8)
Therapeutic aim at admission 463
Curative 447 (96.5)
Palliative and/or limitation of therapy 14 (3.0)
Unknown 2 (0.4)
Diagnosis at admission 613
Respiratory disease 348 (56.8)
Sepsis/infection 72 (11.7)
Trauma 47 (7.7)
Gastrointestinal/abdominal disease 36 (5.9)
Post surgery 32 (5.2)
Neurological disease/neurosurgical intervention 27 (4.4)
Shock/reanimation 15 (2.4)
Cardiac disease 15 (2.4)
Kidney failure 3 (0.5)
Multiple organ failure 3 (0.5)
Metabolic/endocrinological disease 3 (0.5)
Intoxication 1 (0.2)
Other 11 (1.8)
Mortality 700
Death during ICU 235 (33.6)
Discharged alive 465 (66.4)
Length of stay until death/discharge (days) 677 21 [13–34]
a, according to the Berlin definition; b, patients who have been transferred did not statistically significant differ from patients who had not 
been transferred regarding sex, age and severity of ARDS (χ²-tests for sex and severity of ARDS; t-test for age). ICU, intensive care unit; 
ARDS, acute respiratory distress syndrome; Md, median; IQR, interquartile range.
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Table 5 Occurrence of critical events and use of supportive measures in 700 patients with ARDS
Critical events and supportive measures N n (%)
Occurrence of critical events (multiple answers)
Hypoxiaa 670 180 (26.9)
Hypoglycaemiab 676 139 (20.6)
Unintended extubation 683 15 (2.2)
Re-intubation 682 115 (16.9)
Any of the above 684 320 (46.8)
Use of supportive measures (multiple answers)
Tracheotomy 684 363 (53.1)
NO-inhalation 675 80 (11.9)
ECMO 691 216 (31.3)
Prone positioning 683 308 (45.1)
Neuro-muscular blockers 675 70 (10.4)
Prone positioning and/or neuro-muscular blockers and/or ecmo 692 425 (61.4)
ARDS, acute respiratory distress syndrome; ECMO, extracorporeal membrane oxygenation. a, defined as a registration of SpO2 <85% for 
at least 5 minutes; b, defined as blood glucose measurement <70 mg/dL.
In terms of severity, moderate ARDS was most 
frequently recorded, while mild ARDS was only reported 
in 14% of the patients. This observation is in line with 
the generally low oxygenation levels (PaO2/FiO2) of the 
DACAPO cohort and in contrast to the only cohort 
composed of ARDS patients diagnosed on the basis of the 
Berlin definition criteria (23). In this study the proportion 
of patients with mild ARDS was more than twofold higher 
(30%). Potentially, during routine clinical care the mild 
form of ARDS is under-diagnosed and overlooked even in 
university hospitals and/or hospitals providing a maximum 
level of care which participated in our study. Taking a closer 
look at the recorded concomitant illnesses, especially cancer 
and respiratory diseases are frequent in our patient sample. 
Because of a highly heterogeneous selection of concomitant 
diseases reported in the literature, a direct comparison of 
these results with findings of the existing scientific reports 
is very difficult. Some studies report causes or risk factors 
of ARDS while others present comorbidities with varying 
pooling. An obvious difference between the present data 
and results of other studies lies in the lower prevalence of 
sepsis (12%). One possible explanation for this could be 
the explicit recording of one main diagnosis at admission to 
ICU in the DACAPO study, whereas other studies recorded 
multiple diseases. Overall, pulmonary/respiratory diseases 
including pneumonia seem to be one of the most important 
cause or risk factors of ARDS, both in the large cohorts 
described in the literature and in the DACAPO-cohort. 
In addition the present data highlight the high prevalence 
of malignant cancer (active cancer therapy, malignancy 
with metastases, hematological malignancy) in patient with 
ARDS. Only one of the selected studies did address such 
an important comorbidity (25). Since the diagnosis ‘cancer’ 
influences intensive care markedly (29) and has certain 
consequences on the long-term care of surviving ARDS-
patients, the high number of cancer patients in the cohort by 
Vincent et al. (25) and in the present cohort has an impact for 
the health care system and should be re-evaluated in large 
cohorts.
The cause of ARDS was assessed as pulmonary or ‘direct’ 
in 79% of patients. Although criticized by some authors (30), 
the differential assessment of the pathogenesis of ARDS (direct 
versus indirect) seems to be confirmed by recent biological 
findings which underline separate injurious pathways of 
pulmonary and non-pulmonary lung damage (31). 
The high proportion of patients in which critical events 
(hypoglycemia, re-intubation, accidental extubation) (47%) 
occurred is surprising, considering that most participating 
study centres were ICUs of university hospitals or of 
hospitals with a maximum level of care. We found no ARDS 
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specific data regarding the occurrence of critical events, but 
a prospective cohort study in an academic tertiary-care ICU 
revealed a proportion of patients with at least one critical 
adverse event of 19% (32). Furthermore the occurrence 
of such events was associated with longer duration of 
hospitalization. In a more recent study from the Mayo Clinic, 
USA, the effects of adverse events during ICU treatment 
were analyzed retrospectively in 828 acutely ill hospitalized 
patients with sepsis, shock, or pneumonia or undergoing 
high-risk surgery between 2001 and 2010 (32). All analyzed 
patients were at risk for or had developed ARDS. One 
adverse event increased the length of stay in the ICU by 2.4 
(0.6–4.2) days. Beside the high proportion of patients with 
more severe ARDS, the latter finding could be an explanation 
for the extended length of ICU stay of the DACAPO-
cohort (Md =21 days) compared to the cohort described by 
Bellani et al. (23) (Md =10 days). We conclude that the high 
occurrence of critical events in the management of ARDS 
patients is still a field in which patient safety initiatives, 
clinical care and medical education pathways need a better 
integration. Important elements for these initiatives include 
improving the reliability and standardization of processes 
of care, reducing unnecessary variation and complexity, and 
encouraging team working (33).
Finally, we recorded the use of evidence based supportive 
rescue measures in the treatment of ARDS-patients. Prone 
positioning and neuro-muscular blockers were only used 
in the minority of patients, although prone positioning is 
highly recommended in moderate-severe ARDS due to 
evidence from RCTs and meta analysis (34,35) . In addition 
a recent RCT demonstrated benefit of neuromuscular 
blockade in severe ARDS (36), but further studies are 
needed to investigate neuromuscular blockade as routine 
measure. ECMO was applied in 31% of patients, reflecting 
the increasing interest in and use of this technique in 
European countries. ECMO is recommended by a recent 
published consensus in critical hypoxemia despite optimized 
therapy (PaO2/FIO2 <70 for ≥3 hours) (37). In 2015 a survey 
was performed at German ARDS centres to determine 
the current treatment strategies in ARDS patients (11). 
It revealed that in accordance with our findings neuro-
muscular blockers were periodically administered by 
32%, and prone positioning was used by 60% of the 
centres. Thus, there is considerable scope for improving 
bedside implementation of evidence-based pathways in the 
management of ARDS in German ICUs. 
The comparatively low mortality (34%) in our study 
is likely linked to the ARDS diagnosis criteria. While 
most studies applied the obsolete AECC criteria of ARDS 
which comprise only moderate and severe forms, the Berlin 
definition also includes mild ARDS. A comparison with the 
only cohort (23) that applied the Berlin definition criteria as 
we did reveals an almost perfect match of mortality rate. But 
inference has to be drawn considering the differences in the 
distributions of ARDS severity between these two cohorts. 
Strengths of our study include the high number of 
enrolled ARDS patients without the application of any 
exclusion criteria form multiple sites all over Germany, the 
comprehensive assessment of socio-demographic and care-
related data, the use of validated clinical severity scores, data 
collection by a standardized electronic data management 
system, and extensive quality assurance regarding missing and 
erroneous data. Our study also has some limitations: (I) we 
did not perform a registry-based study which is characterized 
by inclusion of all consecutively diagnosed ARDS cases. In 
Germany no institution or health-care regulation for an 
ARDS-registry exists, perhaps the present study might be 
a stimulation to found such a systematic registration; (II) 
there is a strong representation of hospitals belonging to the 
German ARDS network (specialized in the management of 
ARDS), potentially limiting external validity of our results; 
(III) generally, comparisons between data from older studies 
conducted in the ‘pre-Berlin-definition-era’ and data from 
our and other current studies using the Berlin-definition are 
problematic, since different diagnostic criteria are applied. 
Therefore, the investigated patient populations are not 
completely congruent and any conclusions must be drawn 
with caution.
Conclusions
Taking together, we conclude from our real world 
observational study that the characteristics of ARDS 
patients from the DACAPO cohort baseline are similar 
to other large ARDS-cohorts regarding age and sex 
distribution. The ICU-mortality is consistent with the 
mortality recorded by the only other study that applied 
the current Berlin definition of ARDS. Mild ARDS was 
underrepresented in our study, the reason being that it 
seems to be frequently overlooked in everyday routine 
care. Future studies should carefully consider this potential 
source of selection bias. Additionally the present study 
revealed a high occurrence of critical events during 
intensive care treatment. The implementation of evidence-
based medicine (prone positioning and neuro-muscular 
blockers) seems to be still limited, pointing towards 
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opportunities for improving current care. The lack of other 
large observational studies investigating socio-demographic 
characteristics of ARDS patients beyond age and sex is 
striking. We call for more research efforts to go beyond the 
description of medical characteristics and additionally focus 
on socio-demographic characteristics and life circumstances 
as well as comorbidities of patients suffering from ARDS, 
applying the Berlin definition in the first place.
Acknowledgements
We are indebted to all the intensivists and study nurses 
throughout Germany, who, with great commitment, 
recruited patients for the DACAPO study: Aachen, 
University Hospital RWTH Aachen, Department of 
Anesthesiology (Dr. Johannes Bickenbach, Dr. Thorben 
Beeker, Dr. Tobias Schürholz, Jessica Pezechk); Amberg, 
Klinikum Amberg, Department for Anaesthesiology (Dr. 
Jens Schloer); Augsburg, Klinikum Augsburg (Dr. Ulrich 
Jaschinski, Ilse Kreuzer); Bamberg, Sozialstiftung Bamberg 
Hospital, Department for Anaesthesiology (Dr. Oliver 
Kuckein); Berlin, Charité - University Medicine Berlin, 
Department of Anaesthesiology and Intensive Care 
Medicine (Dr. Steffen Weber-Carstens, Dr. Anton 
Goldmann, Dr. Stefan Angermair, Krista Stoycheva); 
Berlin, HELIOS Klinikum Berlin-Buch, Department of 
Intensive Care Medicine (Prof. Dr. Jörg Brederlau, Nadja 
Rieckehr, Gabriele Schreiber, Henriette Haennicke); 
Bielefeld, Ev. Krankenhaus Bielefeld. Department of 
Anesthesiology, Intensive Care Medicine, Emergency 
Medicine and Pain Therapy (Dr. Friedhelm Bach, Dr. 
Immo Gummelt, Dr. Silke Haas, Catharina Middeke, Dr. 
Ina Vedder, Marion Klaproth); Bochum, Ruhr University 
Bochum, Department of Anaesthesiology (Prof. Dr. 
Michael Adamzik, Dr. Jan Karlik, Dr. Stefan Martini, Luisa 
Robitzky); Bonn, University Hospital Bonn, Department of 
Anesthesiology and Intensive Care Medicine (Prof. Dr. 
Christian Putensen, Dr. Thomas Muders, Ute Lohmer); 
Bremen, Klinikum Bremen-Mitte,  Department of 
Anesthesiology (Prof. Dr. Rolf Dembinski); Deggendorf, 
Medical Center, Department of Anaesthesiology and 
Intensive Care Medicine (Dr. Petra Schäffner, Dr. Petra 
Wulff-Werner);  Dortmund, Klinikum Dortmund, 
Department of Critical Care Medicine (Elke Landsiedel-
Mechenbier, Daniela Nickoleit-Bitzenberger, Ann-Kathrin 
Silber); Dresden, University Hospital Dresden Carl Gustav 
Carus, Department of Anesthesiology and Intensive Care 
Medicine (Prof. Dr. Maximilian Ragaller, Prof. Dr. Marcello 
Gama de Abreu, Alin Ulbricht, Linda Reisbach); Frankfurt 
am Main, University Hospital Frankfurt, Department of 
Anaethesiology, Intensive Care Medicine and Pain Therapy 
(Prof. Dr. Kai Zacharowski, Prof. Dr. Patrick Meybohm, 
Karin Pense, Gerhard Schwarzmann, Johannes Reske); 
Freiburg, University Medical Center Freiburg, Department 
of Anaesthesiology and Critical Care Medicine Freiburg 
(Prof. Dr. Alexander Hötzel, Dr. Johannes Kalbhenn); 
F r e i s i n g ,  K l i n i k u m  F r e i s i n g ,  D e p a r t m e n t  o f 
Anaesthesiology (Dr. Christoph Metz, Dr. Stefan Haschka); 
Göppingen, Klinik am Eichert, ALB FILS Kliniken, 
Department of Anaesthesiology and Intensive Care (Dr. 
Stefan Rauch); Göttingen, University Medical Center, 
Department of Anaesthesiology, Emergency and Intensive 
Care Medicine (Prof. Dr. Michael Quintel, Dr. Lars-Olav 
Harnisch, Dr. Sophie Baumann, Andrea Kernchen) ; 
Greifswald, University Medicine Greifswald, Department 
of Internal Medicine B (Dr. Sigrun Friesecke, Sebastian 
Maletzki); Hamburg, University Hospital Hamburg-
Eppendorf, Department of Intensive Care Medicine, 
Center of Anesthesiology and Intensive Care Medicine 
(Prof. Dr. Stefan Kluge, Dr. Olaf Boenisch, Dr. Daniel 
Frings, Birgit Füllekrug, Dr. Nils Jahn, Dr. Knut Kampe, 
Grit Ringeis, Brigitte Singer, Dr. Robin Wüstenberg); 
Hannover, Hannover Medical School, Department of 
Anaesthesiology and Intensive Care Medicine (Dr. Jörg 
Ahrens, Dr. Heiner Ruschulte, Dr. Andre Gerdes, Dr. 
Matthias Groß); Hannover, Hannover Medical School, 
Department of Respiratory Medicine (Dr. Olaf Wiesner, 
Aleksandra Bayat-Graw); Heidelberg, University of 
Heidelberg, Department of Anaesthesiology (Dr. Thorsten 
Brenner, Dr. Felix Schmitt, Anna Lipinski) ; Herford, 
Klinikum Herford, Clinic for Anaesthesiology, Surgical 
Intensive Care Medicine, Emergency Care Medicine, Pain 
Management (Prof. Dr. Dietrich Henzler, Dr. Klaas 
Eickmeyer, Dr. Juliane Krebs, Iris Rodenberg); Homburg, 
Homburg University Medical Centre, Department of 
Anaesthesiology, Intensive Care and Pain Medicine (Dr. 
Heinrich Groesdonk, Kathrin Meiers, Karen Salm, Prof. 
Dr. Thomas Volk); Ibbenbüren, Ibbenbüren General 
Hospital, Division of Thoracic Surgery and Lung Support 
(Prof. Dr. Stefan Fischer, Basam Redwan); Immenstadt, 
Kempten-Oberallgaeu Hospitals, Clinic for Pneumology, 
Thoracic Oncology, Sleep- and Respiratory Critical Care 
(Dr. Martin Schmölz, Dr. Kathrin Schumann-Stoiber, 
Simone Eberl ) ;  Ingolstadt ,  Kl inikum Ingolstadt , 
Department of Anaesthesiology and Critical Care Medicine 
(Prof. Dr. Gunther Lenz, Thomas von Wernitz-Keibel, 
828 Dodoo-Schittko et al. Characteristics of ARDS patients
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
Monika Zackel) ;  Jena,  Jena Univers i ty  Hospital , 
Deptartment of Anesthesiology and Intensive Care Therapy 
(Dr. Frank Bloos, Dr. Petra Bloos, Anke Braune, Anja 
Haucke, Almut Noack, Steffi Kolanos, Heike Kuhnsch, 
Karina Knuhr-Kohlberg); Kassel, Klinikum Kassel, 
Department of Anaesthesiology (Dr. Markus Gehling); 
Kempten, Klinikum Kempten-Oberallgäu gGmbH, 
Department for Anesthesia and Operative Intensive Care 
(Prof. Dr. Mathias Haller, Dr. Anne Sturm, Dr. Jannik 
Rossenbach); Kiel, University Medical Center Schleswig-
Holstein, Campus Kiel, Department of Anesthesiology and 
Intensive Care Medicine (Dr. Dirk Schädler, Stefanie 
D‘Aria); Köln, Cologne-Merheim Hospital, Department of 
Pneumology and Critical Care Medicine (Dr. Christian 
Karagiannidis, Dr. Stephan Straßmann, Prof. Dr. Wolfram 
Windisch); Köln, University Hospital of Cologne, 
Department of Anaesthesiology and Intensive Care 
Medicine (Prof. Dr. Thorsten Annecke, Dr. Holger Herff); 
Langen, Asklepios Kliniken Langen-Seligenstadt, 
Department of Anesthesiology and Intensive Care Medicine 
(Dr. Michael Schütz); Leipzig, University of Leipzig, 
Department of Anesthesiology and Intensive Care Medicine 
(Dr. Sven Bercker, Hannah Reising, Mandy Dathe, 
Christian Schlegel) ; Ludwigsburg, Klinikum Ludwigsburg, 
Academic Teaching Hospital, University of Heidelberg, 
Department  o f  Anaes thes io logy  (Katr in  Lichy) ; 
Ludwigshafen, Klinikum Ludwigshafen, Department of 
Anesthesiology and Intensive Care Medicine (Prof. Dr. 
Wolfgang Zink, Dr. Jana Kötteritzsch); Mainz, University 
Medical Center Mainz, Department of Anaesthesiology (Dr. 
Marc Bodenstein,  Susanne Mauff ,  Peter Straub); 
Magdeburg, Magdeburg University Medical Centre, 
Department of Anaesthesiology and Intensive Care 
Medicine (Dr. Christof Strang, Florian Prätsch, Prof. Dr. 
Thomas Hachenberg); Mannheim, University Medical 
Center Mannheim, Department of Anaesthesiology and 
Surgical Intensive Care Medicine (Dr. Thomas Kirschning, 
Dr. Thomas Friedrich, Dr. Dennis Mangold); Marburg, 
University Hospital, Department of Anaesthesiology (Dr. 
Caroline Rolfes, Tilo Koch); Mönchengladbach, Kliniken 
Maria-Hilf GmbH, Department of Cardiology (Dr. 
Hendrik  Haake ,  Katr in  Offermanns) ;  München, 
Bogenhausen Hospital, Department of Anaesthesiology 
(Prof. Dr. Patrick Friederich, Dr. Florian Bingold); 
München, Klinikum Großhadern,  Department of 
Anaesthesiology (Dr. Michael Irlbeck, Prof. Dr. Bernhard 
Zwissler); München, Klinikum Neuperlach, Städtisches 
Klinikum München GmbH, Department of Anesthesiology, 
Critical Care and Pain Medicine (Dr. Ines Kaufmann); 
München, Klinikum rechts der Isar, Department for 
Anaesthesiology of the Technical University of Munich (Dr. 
Ralph Bogdanski, Dr. Barbara Kapfer, Dr. Markus Heim, 
Dr. Günther Edenharter); Münster, University Hospital 
Münster, Department for Anaesthesiology, Intensive Care 
Medicine and Pain Therapy, (Prof. Dr. Björn Ellger, 
Daniela Bause); Neumarkt, Kliniken des Landkreises 
Neumarkt i.d.OPf, Department for Anaesthesiology and 
Intensive Care Medicine (Dr. Götz Gerresheim); Nürnberg, 
General Hospital Nuremberg, Paracelsus Medical 
University, Department of Emergency Medicine and 
Intensive Care (Dr. Dorothea Muschner, Prof. Dr. Michael 
Christ,  Arnim Geise);  Osnabrück, Marienhospital 
Osnabrück, Department of Anaesthesiology (Dr. Martin 
Beiderlinden, Dr. Thorsten Heuter); Passau, Klinikum 
Passau, Department for Anaesthesiology (Dr. Alexander 
Wipfel); Regensburg, Caritas Krankenhaus St. Josef, 
Department for Anaesthesiology (Dr. Werner Kargl, Dr. 
Marion Harth, Dr. Christian Englmeier); Regensburg, 
Regensburg Univers i ty  Hospita l ,  Department of 
Anaesthesiology, Operative Intensive Care (Prof. Dr. 
Thomas Bein, Dr. Sebastian Blecha, Dr. Kathrin Thomann-
Hackner, Marius Zeder); Stuttgart, Katharinenhospital, 
Department of Anesthesiology (Dr. Markus Stephan); 
Traunstein,  Klinikum Traunstein,  Department of 
Anaesthesiology (Dr. Martin Glaser); Tübingen, Tübingen 
University Hospital, Eberhard-Karls University Tübingen, 
Department of Anaesthesiology and Intensive Care 
Medicine (Dr. Helene Häberle); Ulm, Ulm University, 
Department of Anesthesiology (Prof. Dr. Hendrik Bracht, 
Christian Heer, Theresa Mast); Würzburg, University of 
Würzburg, Department of Anaesthesia and Critical Care 
(Dr. Markus Kredel, Dr. Ralf Müllenbach). 
Further, we are grateful to previous members of the 
Regensburg DACAPO study team (medical documentation: 
Phillip Sebök, study physician: Kathrin Thomann-Hackner) 
to the members of the Advisory Board of the DACAPO-
Study: Prof. Dr. Julika Loss, Prof. Dr. Bernhard Graf, 
Prof. Dr. Michael Leitzmann, Prof. Dr. Michael Pfeifer, 
Regensburg, Germany.
Funding: This work was supported by the German Ministry 
of Education and Research (Bundesministerium für Bildung 
und Forschung) (funding number: 01GY1340).
Footnote
Conflicts of Interest: S Kluge is member of the advisory board 
829Journal of Thoracic Disease, Vol 9, No 3 March 2017
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
of Novalung and gives lectures in contract to Novalung. 
The other authors have no conflicts of interest to declare.
Ethical Statement: The study has been approved by the Ethics 
Committee of the University of Regensburg (file number 
13-101-0262). Additionally approval was confirmed by 
the ethics committees of the participating study centres. 
Written informed consent was obtained from caregivers/legal 
guardians and additionally from those patients who survived 
ICU.
References
1. Matthay MA, Ware LB, Zimmerman GA. The 
acute respiratory distress syndrome. J Clin Invest 
2012;122:2731-40.
2. Bernard GR, Artigas A, Brigham KL, et al. The American-
European Consensus Conference on ARDS. Definitions, 
mechanisms, relevant outcomes, and clinical trial 
coordination. Am J Respir Crit Care Med 1994;149:818-24.
3. ARDS Definition Task Force, Ranieri VM, Rubenfeld 
GD, et al. Acute respiratory distress syndrome: the Berlin 
Definition. JAMA 2012;307:2526-33.
4. Tonelli AR, Zein J, Adams J, et al. Effects of interventions 
on survival in acute respiratory distress syndrome: an 
umbrella review of 159 published randomized trials and 29 
meta-analyses. Intensive Care Med 2014;40:769-87.
5. Price D, Brusselle G, Roche N, et al. Real-world research 
and its importance in respiratory medicine. Breathe 
(Sheffield, England) 2015;11:26-38.
6. Moazed F, Calfee CS. Environmental risk factors for acute 
respiratory distress syndrome. Clinics in chest medicine 
2014;35:625-37.
7. Moss M, Mannino DM. Race and gender differences in 
acute respiratory distress syndrome deaths in the United 
States: an analysis of multiple-cause mortality data (1979- 
1996). Crit Care Med 2002;30:1679-85.
8. Bein T, Hackner K, Zou T, et al. Socioeconomic status, 
severity of disease and level of family members' care in 
adult surgical intensive care patients: the prospective 
ECSSTASI study. Intensive Care Med 2012;38:612-9.
9. Villar J, Sulemanji D, Kacmarek RM. The acute 
respiratory distress syndrome: incidence and mortality, has 
it changed? Curr Opin Crit Care 2014;20:3-9.
10. Wise MP, Hart N, Frost PJ. ARDS outcomes: a marker of 
critical care quality in the UK? Thorax 2011;66:359.
11. Kredel M, Bierbaum D, Lotz C, et al. Therapy of acute 
respiratory distress syndrome : Survey of German 
ARDS centers and scientific evidence. Der Anaesthesist 
2015;64:277-85.
12. Brandstetter S, Dodoo-Schittko F, Blecha S, et al. 
Influence of quality of care and individual patient 
characteristics on quality of life and return to work in 
survivors of the acute respiratory distress syndrome: 
protocol for a prospective, observational, multi-centre 
patient cohort study (DACAPO). BMC Health Serv Res 
2015;15:563.
13. Zensus 2011: Ergebnisse des Zensus / Sachsen-Anhalt, 
Statistisches Landesamt [Internet]. Sachsen-Anhalt / 
Statistisches Landesamt. [cited 2016]. Available online: 
https://ergebnisse.zensus2011.de/#
14. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-
related Organ Failure Assessment) score to describe 
organ dysfunction/failure. On behalf of the Working 
Group on Sepsis-Related Problems of the European 
Society of Intensive Care Medicine. Intensive Care Med 
1996;22:707-10.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified 
Acute Physiology Score (SAPS II) based on a 
European/North American multicenter study. JAMA 
1993;270:2957-63.
16. Bein T, Grasso S, Moerer O, et al. The standard of care 
of patients with ARDS: ventilatory settings and rescue 
therapies for refractory hypoxemia. Intensive Care Med 
2016;42:699-711.
17. Khandelwal N, Hough CL, Bansal A, et al. Long-term 
survival in patients with severe acute respiratory distress 
syndrome and rescue therapies for refractory hypoxemia*. 
Crit Care Med 2014;42:1610-8.
18. ARDS Netzwerk Deutschland. Available online: www.
ardsnetwork.de
19. Villar J, Blanco J, Anon JM, et al. The ALIEN study: 
incidence and outcome of acute respiratory distress 
syndrome in the era of lung protective ventilation. 
Intensive Care Med 2011;37:1932-41.
20. Villar J, Blanco J, del Campo R, et al. Assessment of 
PaO(2)/FiO(2) for stratification of patients with moderate 
and severe acute respiratory distress syndrome. BMJ open 
2015;5:e006812.
21. Villar J, Perez-Mendez L, Blanco J, et al. A universal 
definition of ARDS: the PaO2/FiO2 ratio under a standard 
ventilatory setting--a prospective, multicenter validation 
study. Intensive Care Med 2013;39:583-92.
22. Chen W, Chen YY, Tsai CF, et al. Incidence and Outcomes 
of Acute Respiratory Distress Syndrome: A Nationwide 
Registry-Based Study in Taiwan, 1997 to 2011. Medicine 
830 Dodoo-Schittko et al. Characteristics of ARDS patients
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2017;9(3):818-830jtd.amegroups.com
2015;94:e1849.
23. Bellani G, Laffey JG, Pham T, et al. Epidemiology, 
Patterns of Care, and Mortality for Patients With Acute 
Respiratory Distress Syndrome in Intensive Care Units in 
50 Countries. JAMA 2016;315:788-800.
24. Ferguson ND, Frutos-Vivar F, Esteban A, et al. Airway 
pressures, tidal volumes, and mortality in patients with 
acute respiratory distress syndrome. Crit Care Med 
2005;33:21-30.
25. Vincent JL, Sakr Y, Groeneveld J, et al. ARDS of early or 
late onset: does it make a difference? Chest 2010;137:81-7.
26. Li G, Malinchoc M, Cartin-Ceba R, et al. Eight-year 
trend of acute respiratory distress syndrome: a population-
based study in Olmsted County, Minnesota. Am J Respir 
Crit Care Med 2011;183:59-66.
27. Pandharipande PP, Girard TD, Jackson JC, et al. Long-
term cognitive impairment after critical illness. N Engl J 
Med 2013;369:1306-16.
28. Ehlenbach WJ, Larson EB, Curtis JR, et al. Physical 
Function and Disability After Acute Care and Critical 
Illness Hospitalizations in a Prospective Cohort of Older 
Adults. J Am Geriatr Soc 2015;63:2061-9.
29. Kostakou E, Rovina N, Kyriakopoulou M, et al. Critically 
ill cancer patient in intensive care unit: issues that arise. J 
Crit Care 2014;29:817-22.
30 Rocco PR, Pelosi P. Pulmonary and extrapulmonary acute 
respiratory distress syndrome: myth or reality? Curr Opin 
Crit Care 2008;14:50-5.
31. Shaver CM, Bastarache JA. Clinical and biological 
heterogeneity in acute respiratory distress syndrome: direct 
versus indirect lung injury. Clin Chest Med 2014;35:639-53.
32. Forster AJ, Kyeremanteng K, Hooper J, et al. The impact 
of adverse events in the intensive care unit on hospital 
mortality and length of stay. BMC Health Serv Res 
2008;8:259.
33. Ahmed AH, Thongprayoon C, Schenck LA, et al. Adverse 
in-hospital events are associated with increased in-hospital 
mortality and length of stay in patients with or at risk 
of acute respiratory distress syndrome. Mayo Clin Proc 
2015;90:321-8.
34. Park SY, Kim HJ, Yoo KH, et al. The efficacy and safety of 
prone positioning in adults patients with acute respiratory 
distress syndrome: a meta-analysis of randomized 
controlled trials. J Thorac Dis 2015;7:356-67.
35. Guerin C, Reignier J, Richard JC, et al. Prone positioning 
in severe acute respiratory distress syndrome. N Engl J 
Med 2013;368:2159-68.
36. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular 
blockers in early acute respiratory distress syndrome. N 
Engl J Med 2010;363:1107-16.
37. Richard C, Argaud L, Blet A, et al. Extracorporeal 
life support for patients with acute respiratory distress 
syndrome: report of a Consensus Conference. Ann 
Intensive Care 2014;4:15.
Cite this article as: Dodoo-Schittko F, Brandstetter S, Brandl 
M, Blecha S, Quintel M, Weber-Carstens S, Kluge S, Meybohm 
P, Rolfes C, Ellger B, Bach F, Welte T, Muders T, Thomann-
Hackner K, Bein T, Apfelbacher C. Characteristics and provision 
of care of patients with the acute respiratory distress syndrome: 
descriptive findings from the DACAPO cohort baseline 
and comparison with international findings. J Thorac Dis 
2017;9(3):818-830. doi: 10.21037/jtd.2017.03.120
Table S1 Characteristics of large (N>200) observational studies of ARDS patients and description of patients’ medical and socio-demographic characteristics
Author Study design and recruitment Patients’ medical characteristics Patients’ socio-demographic characteristics
Study design Date, duration and country of recruitment Number of study sites Sample/cohort size ARDS-criteria Causes/risk factors/comorbidity Severity of ARDS Severity of illness: SAPS/Apache/LIS/SOFA ICU-mortality Age (years) Gender (female)
Hughes et al. [2003] (38) Prospective observational 05/1999–12/1999, Great Britain 26 ICUs N=367 AECC Sepsis (40.8%); respiratory infection (29.9%); acute pancreatitis (8.5%); multiple trauma (4.1%); pulmonary 
aspiration (4.4%); other (12.3%); pulmonary (47.4%); extrapulmonary (52.6%)
n/a SAPS II: M=42.4 (95% CI =40.8–44.1); Apache II M=22.3 (95% 
CI =21.6–23.1)
53.1% M=56.8 (95% CI =55.1–58.5) n/a
Brunn-Buisson [2004] (39) Prospective observational 02/1999–03/1999, 10 European countries 78 ICUs N=463 (ALI and ARDS patients) AECC Respiratory failure (45.5%); cardiac failure (34.7%); liver failure (12.8%); renal failure (13.3%); hematological disease 
(8.4%); immunoincompetence (12.9)
ALI (13.4%); ARDS (64.4%) SAPS II: Md =41 (IQR =31–51) 45.8% M=54.7; SD =18.4 36.1%
Ferguson et al. [2005] (24) Prospective observational  1998, international (20 countries) 361 ICUs N=467 AECC Barotrauma (6.4%); pneumonia (45.6%); sepsis (51.2%); shock (51.8%); hepatic failure (10.9%); renal failure 
(37.0%); coagulopathy (24.8%); respiratory acidosis (12.0%); metabolic acidosis (16.1%)
n/a SAPS II: M=46.9, SD =16.5 60.2% M=55.0, SD =17.2 36.6%
Rubenfeld et al. [2005] (40) Prospective observational 04/1999–07/2000, USA 21 hospitals ALI: N=1,113; (ARDS: N=828) AECC n/a n/a n/a ALI: 38.5% (95% CI =34.9–42.2). 
ARDS: 41.1% (95% CI =36.7–45.4)
n/a n/a
Vincent et al. [2010] (25) Prospective observational May 1 to May 15, 2002, Europe 198 ICUs N=393 (ALI- and ARDS-patients) AECC Cancer (12.5%); hematologic cancer (5.3%); diabetes (5.3%); liver cirrhosis (3.1%); AIDS (1.5%) ALI (15.0%); ARDS (85.0%) Early onset of ALI/ARDS (N=254): SAPS II: Md =47 (IQR: 
37–62). SOFA: Md =8 (IQR: 5–11). Late onset of ALI/ARDS 
(N=139): SAPS II: Md =40 (IQR: 31–53); LIS: M=2.9, SD =0.6; 
Apache II: M=21.6, SD =5.9; SOFA: Md =7 (IQR: 4–9).
38.9% Early onset of ALI/ARDS (N=254): Md =62 (IQR: 46-73). 
Late onset of ALI/ARDS (n=139): MD =62 (IQR: 46-73)
28%
Li et al. [2011]b (26) Population-based, retrospective 
cohort study (trend analysis)
2001–2008, USA 2 hospitals N=751 AECC Charlson comorbidity index: Md =18–41 n/a Apache III: Md =64–85 33–48% Md =69–71 15–36%
Villar et al. [2011]a (19) Prospective observational 11/2008–10/2009, Spain 17 hospitals N=255 AECC Pneumonia (42.3%); sepsis (31.4%); trauma (9.4%); aspiration (8.2%); pancreatitis (4.7%); overdose/poisoning 
(1.6%); others (2.3%)
n/a 42.7% Md =58 (IQR: 41–73) 41.3%
Villar et al. [2013]a (21) Prospective cohort (two cohorts) Derivation cohort: 05/2004–10/2005; 
validation cohort: September 2008–
December 2009, Spain
Derivation cohort: 15 ICUs. 
Validation cohort: 17 hospitals
Derivation cohort: N=170. Validation cohort: 
N=282
AECC Derivation cohort: pulmonary (54.7%); non-pulmonary (45.3%); sepsis (28.8%); bacterial pneumonia (27.0%); 
multiple trauma (17.6%); aspiration pneumonia (16.5%); others (10.0%). Validation cohort: pulmonary (50.7%); non-
pulmonary (49.3%); sepsis (32.3%); bacterial pneumonia (33.7%); multiple trauma (11.7%); aspiration pneumonia 
(10.3%); others (12.0%);
n/a Derivation cohort: APACHE II: M=20, SD =8; LIS: M=2.74, 
SD =0.72. Validation cohort: APACHE II: M=21, SD =6; LIS: 
M=2.86, SD =0.62
42% Derivation cohort: M=54 (IQR: 35–66). Validation cohort: 
M=56 (IQR: 40–73)
n/a
Chen et al. [2015] (22) Population-wide claims data 
analysis
1997–2011, Taiwan n/a N=40,876 ICD-9-CM codes 518.82, 518.5 Pneumonia (49.7%); sepsis (33.2%); trauma (29.9%); acute pancreatitis (1.9%) n/a n/a (Hospital-mortality 57.8%) M=66 32.1%
Villar et al. [2015]a (20) Prospective observational 2004–2005 and 2008–2010, Spain 27 hospitals N=478 AECC; additional PEEP ≥5 Pneumonia (26.8%); sepsis (30.1%); trauma (16.7%); aspiration pneumonia (12.5%); others (3.8%) n/a APACHE II: M=21, SD =7; LIS: M=2.9, SD =0.7 (Hospital mortality 42.2%) Md =55 (IQR: 40–70) n/a
Bellani et al. [2016] (23) Prospective observational Four weeks during winter 2014, 
worldwide
459 ICUs N=3,022 (all ARDS patients); N=2,377 (ARDS 
patients, who received invasive ventilation 
and had ARDS on day 1 or 2 after onset of 
acute hypoxic respiratory failure)
Berlin-Definition For the sample n=3,022: pneumonia (59.4%); extrapulmonary sepsis (16.0%); aspiration (14.2%); non-cardiogenic 
shock (7.5%); trauma (4.2%); blood transfusion (3.9%); pulmonary contusion (3.2%); inhalation (2.3%); drug 
overdose (1.9%); pulmonary vasculitis (1.4%); burn (0.3%); drowning (0.1%); other risk factor (2.7%); no risk factor 
(8.3%); COPD (21.7%); diabetes (21.7%); immunoincompetence (12.1%); chronic cardiac failure (10.4%); chronic 
renal failure (10.1%); active neoplasm (8.5%); hematological disease (4.7%)
For the sample (N=2,377): mild 
(30.0%), moderate (46.5%), severe 
(23.4%)
For the sample (N=2,377): SOFA: M=10.1 (95% CI =9.9–10.2) For the sample N=3,022: 34.0%. 
For the sample N=2,377: 35.3%
For the sample (N=3,022): M=61.5 (95% CI =60.9–62.1). 
For the sample (N=2,377): Md =61 (IQR: 61–62)
28.0%
M, mean; SD, standard deviation; Md, median; IQR, interquartile range; 95% CI, 95% confidence interval; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment Score; APACHE, Acute Physiology and Chronic Health Evaluation Score; LIS, Lung Injury Score; n/a, not available. a, there is some overlap between the cohorts reported in Villar 2015, 2013, 2011; b, patient characteristics were reported stratified according to year of recruitment. Ranges of reported medians are given in this table.
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